Development of Rodent Self Administration Vapor Inhalation Chambers for THC

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R44DA041967-01
Agency Tracking Number: R44DA041967
Amount: $1,088,130.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: R44
Solicitation Number: PAR14-088
Timeline
Solicitation Year: 2014
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-04-01
Award End Date (Contract End Date): 2018-03-31
Small Business Information
750 B ST STE 2800, San Diego, CA, 92101-8114
DUNS: 061859422
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 MAURY COLE
 (619) 279-7587
 mcole@ljari.com
Business Contact
 BETTE CESSNA
Phone: (619) 306-3339
Email: cessna@ljari.com
Research Institution
N/A
Abstract
DESCRIPTION provided by applicant This SBIR Phase II proposal will enhance the pace of development and support the eventual commercialization of a self administration vapor inhalation chamber system for the intrapulmonary delivery to rats of tetrahydrocannabinol THC the primary psychoactive constituent of cannabis Cannabis remains the most popular illicit psychoactive drug used in the US Some of year olds have tried cannabis at least once in their lifetime and of year olds have used cannabis in the past month There are more people in the US who meet criteria for cannabis dependence than have used cocaine in the past month or ever tried heroin It is of further concern that the use of cannabis under medical marijuana laws continues to expand Further mechanistic understanding of how dependence of THC develops and the discovery of therapeutics is an increasingly critical goal yet progress has been slowed by the failure of rats to readily self administer THC by the traditional intravenous route The studies in this project seek to further refine our instrumentation to create a reliable rat model of THC self administration via vapor inhalation Studies under Specific Aim will assess the pharmacokinetic distribution of THC as well as effects of intrapulmonary exposure on thermoregulation locomotor activity catalepsy and analgesia to determine necessary exposure parameters The goal is to achieve well controlled exposure under a broad range of plasma THC levels which range from threshold of behavioral effects to doses which can produce dependence with repeated exposure Studies under Aim will establish dependence on THC as well as operant self administration using delivery of volatilized THC as a reinforcer Studies under Aim will test specific instrumentation design changes dictated by Aims and as well as by the preliminary data detailed in the Research Strategy PUBLIC HEALTH RELEVANCE Use of marijuana and therefore the main active constituent tetrahydrocannabinol THC for recreational and therapeutic purposes continues to expand as additional US States legalize medical and recreational use Scientific understanding of compulsive use of and dependence on marijuana has been hampered by a failure of rats to self administer THC intravenously at robust levels The present study will proposes research to enhance the pace of development and commercialization of our self administration vapor inhalation chamber system and create an intrapulmonary self administration model in rats which will support future investigations into THC dependence

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government